Form 4: Surrozen Director-Affiliated Funds Boost Stake
Insider Transaction Report
Funds associated with Surrozen Director Tim Kutzkey acquired additional common stock in the company, increasing their indirect beneficial ownership.
Summary
- Tim Kutzkey, a Director and 10% Owner of Surrozen, Inc. (SRZN), reported indirect acquisitions of common stock.
- On January 6, 2026, The Column Group III, LP acquired 7,097 shares of Surrozen Common Stock at a price of $19.8872 per share.
- Following this transaction, The Column Group III, LP beneficially owns 876,557 shares indirectly.
- Also on January 6, 2026, The Column Group III-A, LP acquired 8,003 shares of Surrozen Common Stock at a price of $19.8872 per share.
- Following this transaction, The Column Group III-A, LP beneficially owns 989,893 shares indirectly.
- Additionally, The Column Group Opportunity III, LP indirectly beneficially owns 344,827 shares of Common Stock.
- Mr. Kutzkey, as a managing partner of the general partners for these entities, may be deemed to share voting and investment power over these securities, but disclaims beneficial ownership except to the extent of his pecuniary interest.
Sentiment
Score: 7
Explanation: The acquisition of additional shares by a director and 10% owner, through affiliated investment funds, is generally viewed as a positive signal, indicating confidence in the company's valuation and future prospects from an insider perspective.
Positives
- A director and 10% owner, through affiliated funds, increased their stake in the company, signaling confidence in Surrozen's future prospects.
- The acquisitions were made at a specific price of $19.8872 per share, providing a clear valuation point for these insider purchases.
Future Outlook
This filing is a report of insider transactions and does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This insider transaction report reflects a specific investment decision by a director and significant shareholder, rather than a broad industry trend. However, insider buying can sometimes be interpreted by the market as a positive signal, suggesting that those closest to the company believe its shares are undervalued or have strong growth potential, which could be relevant in the biotechnology or pharmaceutical sector where Surrozen operates.
Related Party Transactions
- The reported transactions involve the acquisition of Surrozen, Inc. common stock by investment funds (The Column Group III, LP and The Column Group III-A, LP) where Tim Kutzkey, a Director and 10% Owner of Surrozen, Inc., serves as a managing partner of their general partners. This establishes a related party transaction as Mr. Kutzkey may be deemed to share voting and investment power over these securities.
Stakeholder Impact
- Shareholders may interpret the insider buying as a positive indicator of management and significant investor confidence in the company's value and future performance, potentially influencing investor sentiment and stock price.
Key Dates
| Date | Description |
|---|---|
| 01/06/2026 | Date of common stock acquisition transactions by affiliated funds. |
| 01/08/2026 | Date the Form 4 was signed and filed. |
Recommendation
buyThe acquisition of additional shares by a director and 10% owner, through affiliated funds, suggests strong insider confidence in Surrozen's current valuation and future prospects. Such insider buying often precedes positive company developments or reflects a belief that the stock is undervalued, making it a 'buy' signal for seasoned investors.
Keywords
Surrozen, SRZN, Insider Buying, Beneficial Ownership, Director, 10% Owner, Stock Acquisition, Form 4, The Column Group
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.